For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs—commonly referred to as antiretroviral therapy—the virus usually rushes ...

A draft State Department memo outlines ways the Trump administration may ratchet up pressure on the African country by ending health support “on a massive scale.” By Stephanie Nolen Reporting from ...

A cornerstone of the effort to combat the nation's HIV epidemic is beginning to show fiscal cracks. The Ryan White HIV/AIDS Program has helped more than a quarter million Americans living with HIV to ...

Is there one pill a day to keep me healthy? That's a question that Dr. Chloe Orkin hears a lot from her older HIV patients who take many medications each day to keep the virus under control. "They ...

A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in hard-to-treat patients. It’s “a potential breakthrough for a growing cohort of ...

The invasion of Ukraine has stymied health care services, allowing diseases such as HIV to spread unchecked. The rate of contagion has been difficult to gauge. But now, using a van equipped with ...

Drug conjugates (ADCs) developed at Institute of Science Tokyo combine a CD4 mimic with neutralizing antibodies for enhanced suppression of human immunodeficiency virus (HIV) infection. By targeting ...

More than 30 million people with HIV must take antiretroviral therapy (ART) medications daily to keep the virus under control, according to the Joint United Nations Programme on HIV/AIDS (UNAIDS). The ...

Nearly 45 years after the first HIV diagnosis, science is closer than ever to a cure for the virus that causes AIDS — but we’re not there yet, researchers say. While perhaps a dozen people worldwide ...

A small, highly anticipated study shows a glimmer of hope in the long effort to control HIV without medication and search for a cure for a virus that attacks immune cells. Researchers gave 10 people ...

A new study from UC San Francisco shows it may be possible to control HIV without long-term antiviral treatment — an advance that points the way toward a possible cure for a disease that affects 40 ...

Merck & Co. has reported another phase 3 win for islatravir in HIV, advancing its efforts to establish the near-approval molecule as a new anchor treatment for the infectious disease. Integrase strand ...